Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matias Ryding

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
CNS & Neurological Disorders Drug Targets|July 10, 2020
Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and TreatmentMette Scheller Nissen, Matias Ryding, Morten Meyer, et al.
Ugeskrift for Laeger|June 25, 2021
[Autoimmune encephalitis]Anna Christine Nilsson, Mette Scheller Nissen, Matias Ryding, et al.
Ugeskrift for Laeger|March 31, 2023
Anna Christine Nilsson, Matias Ryding, Charlotte Aaberg Poulsen, et al.
Cells|January 11, 2024
Pathophysiological Effects of Autoantibodies in Autoimmune EncephalitidesMatias Ryding, Anne With Mikkelsen, Mette Scheller Nissen, et al.
Journal of Neurology|August 5, 2021
NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort studyMette Scheller Nissen, Maren Synnøve Ørvik, Anna Christine Nilsson, et al.
The European Journal of Neuroscience|November 25, 2018
Nonhypoxic pharmacological stabilization of Hypoxia Inducible Factor 1α: Effects on dopaminergic differentiation of human neural stem cellsSabine Morris Hey, Pia Jensen, Matias Ryding, et al.
European Journal of Pharmacology|December 21, 2020
Role of RhoA-ROCK signaling in Parkinson's diseaseMahalaxmi Iyer, Mohana Devi Subramaniam, Dhivya Venkatesan, et al.
Cells|April 30, 2021
Neurodegeneration Induced by Anti-IgLON5 Antibodies Studied in Induced Pluripotent Stem Cell-Derived Human NeuronsMatias Ryding, Mattias Gamre, Mette S Nissen, et al.
Scientific Reports|June 26, 2020
Lysosomal perturbations in human dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutationJustyna Okarmus, Helle Bogetofte, Sissel Ida Schmidt, et al.
Frontiers in Immunology|January 3, 2022
CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort StudyMette Scheller Nissen, Matias Ryding, Anna Christine Nilsson, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
CNS & Neurological Disorders Drug Targets|July 10, 2020
Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and TreatmentMette Scheller Nissen, Matias Ryding, Morten Meyer, et al.
Ugeskrift for Laeger|June 25, 2021
[Autoimmune encephalitis]Anna Christine Nilsson, Mette Scheller Nissen, Matias Ryding, et al.
Ugeskrift for Laeger|March 31, 2023
Anna Christine Nilsson, Matias Ryding, Charlotte Aaberg Poulsen, et al.
Cells|January 11, 2024
Pathophysiological Effects of Autoantibodies in Autoimmune EncephalitidesMatias Ryding, Anne With Mikkelsen, Mette Scheller Nissen, et al.
Journal of Neurology|August 5, 2021
NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort studyMette Scheller Nissen, Maren Synnøve Ørvik, Anna Christine Nilsson, et al.
The European Journal of Neuroscience|November 25, 2018
Nonhypoxic pharmacological stabilization of Hypoxia Inducible Factor 1α: Effects on dopaminergic differentiation of human neural stem cellsSabine Morris Hey, Pia Jensen, Matias Ryding, et al.
European Journal of Pharmacology|December 21, 2020
Role of RhoA-ROCK signaling in Parkinson's diseaseMahalaxmi Iyer, Mohana Devi Subramaniam, Dhivya Venkatesan, et al.
Cells|April 30, 2021
Neurodegeneration Induced by Anti-IgLON5 Antibodies Studied in Induced Pluripotent Stem Cell-Derived Human NeuronsMatias Ryding, Mattias Gamre, Mette S Nissen, et al.
Scientific Reports|June 26, 2020
Lysosomal perturbations in human dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutationJustyna Okarmus, Helle Bogetofte, Sissel Ida Schmidt, et al.
Frontiers in Immunology|January 3, 2022
CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort StudyMette Scheller Nissen, Matias Ryding, Anna Christine Nilsson, et al.
Pageof 2